Insider · CIK 0001598549
Andrew J. Schwab
Files at SKYE (Skye Bioscience, Inc.), TRDA (Entrada Therapeutics, Inc.), CAMP (Camp4 Therapeutics Corp). First filing Oct 15, 2024, latest Sep 24, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
SKYE: Skye Bioscience, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
CAMP: Camp4 Therapeutics Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Skye Bioscience, Inc. | $240k 148,079 shares | -104% | +9% from low-96% from high | |
| 36Weak | Skye Bioscience, Inc. | $65k 33,892 shares | -19% | +1% from low-96% from high | |
| 50Moderate | Skye Bioscience, Inc. | $801k 231,405 shares | -14% | +196% from low-44% from high | |
| 65Notable | Camp4 Therapeutics Corp | $10.0M 909,090 shares | +53% | +10% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Ventures II, L.P. | -27,612 | $1.65 | $46k | 114,851 | 18 d ago |
| Sep 22, 2026 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Co-Investors II, L.P. | -1,088 | $1.65 | $1,795 | 4,528 | 18 d ago |
| Sep 23, 2026 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Ventures II, L.P. | -114,851 | $1.61 | $185k | 0 | 18 d ago |
| Sep 23, 2026 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Co-Investors II, L.P. | -4,528 | $1.61 | $7,290 | 0 | 18 d ago |
| Sep 16, 2026 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Ventures II, L.P. | -32,607 | $1.91 | $62k | 142,463 | 24 d ago |
| Sep 16, 2026 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Co-Investors II, L.P. | -1,285 | $1.91 | $2,454 | 5,616 | 24 d ago |
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Common Stockindirect: By 5AM Ventures VII, L.P. | +2,941,176 | $1.53 | $4.5M | 2,941,176 | Sep 15, 2025 |
| Aug 21, 2025 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Ventures II, L.P. | -58,642 | $3.57 | $209k | 1,621,043 | Aug 22, 2025 |
| Aug 21, 2025 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Co-Investors II, L.P. | -2,314 | $3.57 | $8,261 | 63,963 | Aug 22, 2025 |
| Aug 22, 2025 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Ventures II, L.P. | -163,979 | $3.42 | $561k | 1,457,064 | Aug 22, 2025 |
| Aug 22, 2025 | SKYE Skye Bioscience, Inc. | SOpen-market sale Common Stockindirect: By 5AM Co-Investors II, L.P. | -6,470 | $3.42 | $22k | 57,493 | Aug 22, 2025 |
| Jun 25, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +9,000 | $0.00 | $0 | 9,000 | Jun 27, 2025 |
| Oct 28, 2024 | SKYE Skye Bioscience, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Oct 30, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stockindirect: See Footnote | +1,337,592 | - | - | 1,337,592 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stockindirect: See Footnote | +378,463 | - | - | 1,716,055 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stockindirect: See Footnote | +302,770 | - | - | 302,770 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | POpen-market purchase Common Stockindirect: See Footnote | +909,090 | $11.00 | $10.0M | 2,625,145 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series A Prime Preferred Stockderivativeindirect: See Footnote | -15,002,166 | - | - | 0 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series B Preferred Stockderivativeindirect: See Footnote | -4,244,770 | - | - | 0 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series B Preferred Stockderivativeindirect: See Footnote | -3,395,816 | - | - | 0 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.